Risk of iron overload with chronic indiscriminate use of intravenous iron products in ESRD and IBD populations.
Heliyon
; 5(7): e02045, 2019 Jul.
Article
de En
| MEDLINE
| ID: mdl-31338466
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Type d'étude:
Etiology_studies
/
Risk_factors_studies
Langue:
En
Journal:
Heliyon
Année:
2019
Type de document:
Article
Pays d'affiliation:
France
Pays de publication:
Royaume-Uni